A股異動丨萬里揚(002434.SZ)大漲超7% 股價創10個月新高
格隆匯9月24日丨昨日漲停的萬里揚(002434.SZ)續升超7%,報10.9元創10個月新高價,成交額放大至7.46億元,總市值147億元。公司先後與日立、博世強強聯合發展新能車用產品,目前多款產品已進入裝車試驗階段,有望逐步實現量產上市,加速放量。另外,公司已形成180萬台乘用車和110萬台商用車變速器以及10萬台新能車用EV減速器產能。信達證券首予萬里揚“買入”評級,全球汽車電動化提升,公司加速相關產品佈局。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.